← Back to Search

Mechanical Circulatory Support Device

The Use of Impella RP Support System in Patients With Right Heart Failure

N/A
Waitlist Available
Led By Mark Anderson, MD
Research Sponsored by Abiomed Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group

Summary

The use of Impella RP is safe, feasible and provides a hemodynamic benefit in patients with right ventricular failure.

Eligible Conditions
  • Cor Pulmonale

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary Benefit Endpoint

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Abiomed Inc.Lead Sponsor
44 Previous Clinical Trials
33,578 Total Patients Enrolled
Mark Anderson, MDPrincipal InvestigatorAlbert Einstein Medical Center
1 Previous Clinical Trials
1,017 Total Patients Enrolled
William O.Neill, MDPrincipal InvestigatorHenry Ford Hospital
~2 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top